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Translation modulates the timing and amplification of gene expression after transcription. Development of the 
brain’s neocortex requires precisely timed and spatially targeted gene expression, but the relationship between 
mRNA vs. protein synthesis throughout the genome is unknown. We perform a comprehensive analysis of the 
reactants, synthesis, and products of mRNA translation spanning mouse neocortex neurogenesis. Ribosome 
number in the cortical plate decreases sharply at mid-neurogenesis during a transition in neuronal subtype 
specification, shifting the fundamental kinetics of protein synthesis, with mRNA and protein levels frequently 
divergent. Satb2, which drives an essential neuronal subtype-specific program, is a highly dynamically 
translated mRNA with surprisingly broad transcription across diverse neuronal lineages. Satb2 protein 
achieves its neuronal subtype expression through timed regulation by the RNA-binding protein Pumilio2. Thus, 
the refinement of transcriptional programs by protein synthesis is a widespread feature of neuronal 
specification. Developmental neocortex translatome data are provided in an open-source resource: 
https://shiny.mdc-berlin.de/cortexomics/. 
INTRODUCTION 
Discrepancy between the levels of mRNA and protein 
often reflect dynamic cellular transition states 
(Buccitelli and Selbach, 2020). Timed cellular 
transitions pattern the nervous system during 
development, specifying stem cells into diverse 
neuronal lineages. Historically, transcription has been 
a principal focus of mechanisms driving nervous 
system patterning. A canonical example is spinal 
cord formation, which is driven by a Homeobox 
transcription factor code that sharply demarcates 
distinct circuits  (Catela et al., 2015). However, in the 
more evolutionarily advanced mammalian neocortex, 
transcriptional signatures alone are insufficient to 
account for the enormous cellular complexity of the 
neocortex circuit. Recent single-cell RNA sequencing 
(scRNA-seq) analyses of neocortex development 
support this idea (Nowakowski et al., 2017; Telley et 
al., 2019; Zahr et al., 2018). For example, Telley et al. 
found that mRNA measurements are highly 
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made 
The copyright holder for this preprintthis version posted June 24, 2021. ; https://doi.org/10.1101/2021.06.23.449626doi: bioRxiv preprint 
	 2 
overlapping in differentiating neurons of distinct 
birthdates, locations, and circuits. Even further, 
transcription factors historically assigned to neurons 
in distinct cortical regions are also robustly expressed 
in astrocytes in the same region (Herrero-Navarro et 
al., 2021). These recent revelations suggest that 
transcriptional signatures defining cell and circuit type 
in the developing neocortex are less sharply 
demarcated. Thus, the blueprint of gene expression 
in neocortex development is likely multilayered, 
including and beyond transcription (Cadwell et al., 
2019; Hoye and Silver, 2021; Kraushar et al., 2016; 
Telley and Jabaudon, 2018).      
 
The neurogenic phase of neocortex development is a 
tightly controlled spatial and temporal program of 
tissue patterning (Figure 1A) (DeBoer et al., 2013; 
Greig et al., 2013). In mice, at approximately 
embryonic day 12.5 (E12.5) neural stem cells in the 
cortical ventricular zone begin to generate neurons. 
These early-born immature neurons migrate 
superficially to laminate lower layers of the nascent 
cortical plate, and will ultimately form predominantly 
subcortically projecting neuronal circuits that express 
cell fate determinants like Bcl11b (Arlotta et al., 2005). 
Later at mid-neurogenesis ~ E15.5, neural stem cell 
divisions almost exclusively generate upper layer 
neurons. These late-born neurons migrate past 
previously formed lower layers, with adjacent upper 
layers projecting distinct, intracortical neuronal 
circuits that express cell fate determinants like Satb2 
(Alcamo et al., 2008; Britanova et al., 2008). 
Distinguishing mRNA features of early vs. late-born 
neural stem cells are reversible with heterochronic 
transplantation and fade with differentiation, 
superseded by largely generic maturation-associated 
transcriptional states (Oberst et al., 2019; Telley et al., 
2019).         
 
The final essential step of gene expression is mRNA 
translation by the ribosome. Direct measurements of 
protein synthesis may provide a clearer picture of 
functional gene expression in the neocortex; however, 
a large-scale high-resolution analysis of mRNA 
translation during neurogenesis has lagged behind 
transcriptome analysis, in part due to current 
technical limitations in protein measurement. Recent 
work suggests that targeted and selective protein 
synthesis refines the output of gene expression in 
neocortex development (Kraushar et al., 2014, 2015, 
2021; Popovitchenko et al., 2020; Zahr et al., 2018, 
2019). Importantly, abnormal neocortex ribosome 
levels and disrupted translation was found recently to 
be a mid-gestation etiology of neurodevelopmental 
disorders (Kalish et al., 2021). However, how 
ribosomes decode mRNA in the transcriptome-to-
proteome transition during neocortex neurogenesis 
remains unknown.  
 
To circumvent these challenges and measure the 
temporal dynamics of the reactants, synthesis, and 
products of mRNA translation during neocortex 
development, we performed sequencing of ribosome-
protected mRNA fragments (Ribo-seq; ribosome 
profiling) (Ingolia et al., 2009) in parallel with RNA-
seq, tRNA qPCR array, and mass spectrometry 
across five stages of mouse neocortex neurogenesis. 
By capturing ribosome-mRNA interactions at codon-
level resolution, we find that ~18% of mRNAs change 
translation efficiency in the progressive specification 
of neural stem cells to post-mitotic neurons. 
Ribosome numbers decrease sharply at mid-
neurogenesis E15.5 in the cortical plate, coinciding 
with striking changes in translation initiation and 
elongation speed, and frequently divergent mRNA 
and protein levels in the neocortex.  
 
We previously reported that Satb2 acts as an 
essential post-mitotic determinant of upper layer 
neurons (Britanova et al., 2008). Satb2 is among the 
most translationally upregulated mRNAs discovered 
in our data, and here reveal that Satb2 is 
unexpectedly transcribed broadly, including in the 
earliest-born neural stem cell lineage generating 
lower layers. Precocious Satb2 translation is 
prevented during the early period of ribosome 
abundance by the translation repressor Pumilio2, 
restricting its ultimate expression in broadly primed 
progenitors. Thus, by mapping the quantitative 
landscape of the transcriptome-to-proteome 
transition in the neocortex, we find that protein 
synthesis is a powerful and widespread layer of gene 
expression regulation that fundamentally shifts 
kinetics and impacts neuronal specification during 
development. We provide the developmental 
neocortex translatome as an open-source searchable 




Deep sequencing of protein synthesis at high 
resolution across neocortex neurogenesis  
We designed a strategy to analyze the major 
reactants, synthesis, and products of mRNA 
translation across five stages encompassing 
neocortex neurogenesis (Figure 1A), including Ribo-
seq measurement of ribosome-mRNA interactions. 
Ribo-seq measures 80S ribosomes bound to the 
open reading frame of mRNA – a quantitative 
indicator of active protein synthesis at codon-level 
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Figure 1. Translation drives acute ribosome downregulation at mid-neurogenesis.  
(A) Developmental trajectory of neural stem cell differentiation in the neocortex, analyzed by RNA-seq, Ribo-seq, tRNA qPCR 
array, and MS at five stages. (B) Schematic of translation efficiency (TE). (C) Measurements of steady-state mRNA, ribosome-
protected mRNA fragments (RPF), and TE calculated per gene. High-count filtering applied for quality-control (>32, black; <32, 
grey). (D) TE vs. steady state mRNA fold change (FC) at E12.5 compared to each subsequent stage. Significance assessed at 
≥ 1.25 FC, p < 0.05. Not significant (n.s.). (E) Gene ontology (GO, molecular function) analysis of translationally down-regulated 
(TE down) and up-regulated (TE up) mRNAs. Top six rank-ordered significant pathways shown. (F) Transcriptome-to-proteome 
expression trajectory of ribosomal protein coding mRNAs of the large (Rpl) and small (Rps) subunits from E12.5 (t0) to subsequent 
stages (t). (G) Immuno-electron microscopy labeling ribosomal protein uS7 in the E12.5 and E15.5 neocortex (magenta), with 
(H) quantification for ribosomes per cytoplasmic area. Mean shown (dotted line), Welch’s ANOVA and Dunnett’s post hoc test, 
***p < 0.001. Neural stem cells are located in the ventricular zone (VZ) and sub-ventricular zone (SVZ); post-mitotic neurons are 
located in the cortical plate (CP), lower layers (LL), upper layers (UL). Nuclei are outlined. See also Figures S1-3. 
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resolution (Ingolia et al., 2009). Optimizations for 
analysis of neocortex ribosomes ex vivo 
circumvented the requirement for pharmacological 
ribosome stalling with cycloheximide (Kraushar et al., 
2021), which introduces ribosome footprint 
redistribution artifacts (Ingolia, 2016), and enabled 
efficient nuclease digestion to generate high fidelity 
ribosome-protected mRNA fragments (RPFs) (Figure 
S1A-D). Quantifying both RNA-seq and Ribo-seq in 
an isoform-aware fashion, we obtained transcripts 
per-million (TPM) and RPF densities for 22,373 
genes (Figure S2A, Table S1). Reproducibility of 
both RNA and RPF measurements permitted reliable 
calculation of mRNA translation efficiency (Figure 
S1E), which represents the ratio between total 
ribosome binding to an mRNA’s coding sequence 
(sum of RPFs) and the mRNA’s level overall (sum of 
TPMs) (Figure 1B-C). As a quality control, we 
focused further analysis on coding sequences with 
32 or more Ribo-seq footprints in at least one stage 
as per (Dunn et al., 2013), which resulted in a set of 
12,228  translated GENCODE-annotated transcripts.  
 
While the majority of mRNAs are translated in high 
correlation to their steady state levels, subsets of 
mRNAs are heavily translated despite low 
abundance, or weakly translated while highly 
abundant – indicating substantial translation 
regulation (Figure 1C). Concordant with previous 
observations in yeast (Ingolia et al., 2009), we found 
an ~ 100-fold variation in translation efficiency among 
expressed open reading frames, compared to the ~ 
10,000-fold variation in RNA expression (Figure 
S2B-C). 
 
We next assessed the timing and distribution of 
dynamic translation fold changes after early 
neurogenesis at E12.5 (Figures 1D and S2D, Table 
S2). While both translation efficiency and steady 
state mRNA per gene are largely stable between 
E12.5-E14, a burst of gene expression regulation 
occurs at E15.5, during a timed developmental shift 
in lower to upper layer neurogenesis. Translation 
efficiency upregulation was found to occur in 1,129 
genes and downregulation in 1,131 genes – with only 
7 genes both translation up- and downregulated 
across development. A further 2,253 genes change 
in steady state mRNA only, without any significant 
translation efficiency change. Thus, we estimate ~ 
18% of the transcriptome is dynamically translated 
across neocortex neurogenesis, with an acute 
inflection point during the mid-neurogenesis transition. 
 
Gene ontology analysis revealed distinct molecular 
pathways are impacted by upregulated vs. 
downregulated translation efficiency (Figure 1E). As 
neurogenesis progresses, mRNAs coding for 
structural constituents of the ribosome – 
predominantly ribosomal proteins – decrease in 
translation.  In contrast, genes associated with 
chromatin binding, such as transcription factors, 
increase in translation.      
 
Translation downregulates ribosome levels 
acutely at mid-neurogenesis 
To begin investigating whether timed changes in the 
translation of ribosome-associated proteins 
reorganizes gene expression during development, 
we next calculated the developmental expression 
trajectory of all ribosomal proteins in the large and 
small subunits by RNA-seq, Ribo-seq, mass 
spectrometry (MS), and translation efficiency (Figure 
1F). Results showed downregulation of nearly all 
ribosomal proteins at the Ribo-seq and MS level 
occurs acutely at E15.5, in advance of changes 
measured by RNA-seq, and reflecting translation 
downregulation until mid-neurogenesis. Decreasing 
ribosome levels by downregulation of ribosomal 
protein translation likely represents the coordinated 
regulation of this specific gene family, rather than a 
simple translation feedback loop, since numerous 
genes in other families undergo translation 
upregulation concurrently.  
  
To visualize changing ribosome numbers sub-
cellularly at high resolution, we performed immuno-
electron microscopy analysis labeling ribosomal 
protein uS7 at E12.5 and E15.5 in the neocortex 
(Figures 1G-H and S3). A striking difference in 
ribosome number was observed in differentiating 
neurons between early and late stages. Ribosomes 
are abundant in cortical plate neurons at E12.5, but 
scarce in both upper and lower layer neurons of the 
cortical plate at E15.5. Notably, a progressive 
increase in ribosome number was observed as newly 
born neurons traverse away from the ventricular zone 
into the cortical plate at E12.5; while at E15.5, 
ribosome numbers decrease precipitously outside the 
ventricular zone, with few ribosomes measured in 
sub-ventricular zone intermediate progenitors. Thus, 
ribosome number is temporally encoded by 
translation at mid-gestation. Acute changes in 
ribosome number coincide with a critical period when 
translation is highly sensitive to a compromised 
maternal-fetal environment (Kalish et al., 2021). As 
ribosome abundance is a powerful determinant of 
translation kinetics and selectivity (Mills and Green, 
2017; Shah et al., 2013), global shifts in translation 
activity may occur at mid-neurogenesis. 
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Figure 2. Start codon translation kinetics slow sharply at mid-neurogenesis.    
(A) Ribosome occupancy metagene plot including all mRNAs (top) surrounding the start (left) and stop (right) codons at five 
stages. Separation of mRNAs by changing or unchanged start codon occupancy (bottom). (B) Position specific fold changes in 
ribosome P-site counts surrounding the start and stop codons. (C) Start (left) and stop (right) codon occupancy vs. TE fold change 
between E12.5 and E17. (D) GO analysis of mRNAs with increasing start codon occupancy (molecular function, MF; biological 
process, BP). Top seven rank-ordered significant pathways shown. See also Figure S2.  
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Translation initiation and termination in the 
mRNA coding sequence are developmentally 
dynamic 
We next examined global translation activity during 
neocortex development by determining ribosome-
mRNA interactions per-codon across all coding 
sequences. Ribosome position aligned to codons in 
the P-site demonstrated the characteristic 3-
nucleotide periodicity in Ribo-seq metagene plots 
(Figure 2A). Ribosome occupancy surrounding the 
start codon increases sharply at E15.5, with 
progressive increases per stage until P0, while stop 
codon occupancy demonstrates the opposite trend 
and occurs independent of start codon changes. We 
applied RiboDiPA (Li et al., 2020), a linear modeling 
framework designed for positional analysis of Ribo-
seq signal, to pinpoint the ~5-fold ribosome 
occupancy changes to the 4 codon bin surrounding 
the start and stop (Figure 2B).  
 
Increased ribosome occupancy of the first four 
codons over time could represent a narrowing 
bottleneck in the transition from initiation to 
elongation, or signify increasingly robust initiation of 
target mRNAs. To begin distinguishing between 
these possibilities, we correlated fold changes in start 
codon occupancy with translation efficiency, and 
found an inverse relationship (Figure 2C). N-terminal 
translation thus may be rate-limiting to synthesize 
Sbno2 and Pcdhgc4, in contrast to Tuba1c and 
Tuba1b representing more processive translation 
during development. Gene ontology analysis of 
mRNAs with increasing ribosome occupancy at the 
start codon showed enrichment for pathways like 
microtubule binding and neuron projection 
maintenance, concurrent with the differentiation of 
neuronal morphology (Figure 2D). Translation and 
ribosome-associated pathways were also highly 
associated with increased start occupancy, 
concordant with translation downregulation of 
ribosomes in Figure 1E-H. Thus, as ribosome levels 
decline at E15.5 to P0, translation at the 5’-end of 
coding sequences occurs more slowly. 
 
The kinetics of translation elongation per-codon 
fundamentally shift at mid-neurogenesis 
Translation efficiency is a simple global sum, and 
does not reflect complex local variations in ribosome 
density on an mRNA. With developmental changes 
observed in ribosome number, translation efficiency, 
and at the start and stop of coding sequences, we 
next analyzed ribosome dwell time per codon – a 
measure of the codon-specific speed of translation 
(Gobet et al., 2020). We found that ribosomes early 
in development translate with codon-specific “fast” or 
“slow” kinetics, seen in the bimodal distribution of 
codon dwell times at E12.4-E14 (Figure 3A top left, 
and Table S3), and further observed in metacodon 
plots (Figure S4A-B). At mid-neurogenesis, codon 
dwell times begin to equalize, progressively reaching 
a unimodal distribution by P0. Thus, early-stage 
kinetic barriers in ribosome-codon interactions relax 
from mid to late neurogenesis.   
 
Varying ribosome dwell time on a codon might be 
attributable to the availability of a given tRNA. Dwell 
time is strongly correlated with tRNA abundance in 
yeast (Fang et al., 2018; Riba et al., 2019; Weinberg 
et al., 2016), but is less correlated in some 
mammalian systems (Gobet et al., 2020; Ingolia et al., 
2011). To determine if tRNA abundance is 
responsible for driving ribosome dwell time 
differences in the developing neocortex, we 
measured levels of 151 tRNA isodecoders by 
quantitative PCR (qPCR) array at each stage (Figure 
S5). As expected, tRNA levels showed robust 
correlation with overall codon usage in the 
transcriptome (Figure 3A). However, we did not 
observe a correlation between tRNA abundance and 
ribosome dwell time per codon, or after correcting 
codon dwell times for their corresponding amino 
acids. Usage-corrected tRNA abundance 
(availability) (Gobet et al., 2020) and codon optimality 
– the non-uniform decoding rate between 
synonymous codons (dos Reis et al., 2004) – also 
failed to show any correlation with ribosome dwell 
time (Figure S4C). 
 
While overall tRNA abundance/scarcity does not 
explain the observed codon dwell time variation, we 
did find that the spectrum of high and low dwell times 
detected at early developmental stages were partially 
associated with “proliferation” vs. “differentiation” 
codons, i.e. codons more heavily utilized in genes 
with proliferation vs. differentiation functions (Gingold 
et al., 2014) (Figure 3B). Proliferation-associated 
codons were more highly represented in short 
ribosome dwell times, while differentiation codons 
more represented by long dwell times. Notably, 
differentiation associated codons demonstrate G/C 
biases (Gingold et al., 2014), which we detected as a 
feature likewise correlated with longer dwell times 
(Figure S4D). However, dwell times for codons in 
both of these classes are overlapping and normalize 
at later developmental stages, and thus are not 
sufficient to account for the spectrum of dynamic 
ribosome-codon interactions.  
 
We next investigated distinct positions where 
variations in ribosome dwell time take place 
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Figure 3. A-site amino acid processivity is a barrier driving ribosome dwell time that relaxes at mid-neurogenesis.  
(A) Correlations between per-codon ribosome dwell time and corresponding tRNA measurements across developmental stages. 
Rho and p-values are shown when significant. Each variable’s distribution is shown on the diagonal. Amino acid corrected (AAcor). 
(B) The distribution of codon dwell times at each developmental stage for proliferation and differentiation associated codons 
measured in (Gingold et al., 2014). (C) Variation in codon identity occupying ribosomal A-, P-, and E-sites at each developmental 
stage. (D) Ribosome A-site dwell time for each amino acid with corresponding synonymous codons across developmental stages. 
(E) Schematic of dynamic translation kinetics during neocortex development. See also Figures S4-5. 
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(O’Connor et al., 2016) (Figure 3C; see Methods). A 
narrow region consistent with the ribosomal A-site 
accounts for most of the codon-specific variation in 
ribosome dwell time. Variation in A-site occupancy 
was most pronounced at E12.5-E14, with an acute 
decrease at E15.5-E17, and low variation by P0, 
consistent with results above (Figure 3A). Thus, the 
A-site codon in particular influences ribosome dwell 
time, which is a barrier most pronounced early in 
neurogenesis when ribosome levels are highest, and 
less pronounced after mid-neurogenesis when 
ribosome levels decline.      
 
Focusing on the ribosome A-site, we found that the 
amino acid coded for is a strong determinant of 
codon dwell time, with synonymous codons showing 
similar dwell times (Figure 3D). Codons for acidic 
amino acids are among those with the highest dwell 
time, suggesting they represent a kinetic barrier in 
early development translation (Chadani et al., 2017; 
Riba et al., 2019). E12.5-E14 accounts for the 
extremes of A-site dwell time differences between 
amino acids and among synonymous codons, with a 
progressive, chronologic trend towards equalized 
dwell time by P0. Thus, the bimodal codon dwell time 
distributions at E12.5-E14 are due to a transient 
impact of A-site amino acids (Figure 3A). Some 
amino acids like leucine and isoleucine are coded for 
by both “fast” and “slow” synonymous codons, 
particularly apparent early in development, such as 
the fast TTA-Leu and slow CTG-Leu. Neither codon 
optimality (Figure S4C) nor codon rarity would 
account for such dwell time differences, as TTA-Leu 
is a relatively rare codon (Quax et al., 2015) with a 
short dwell time, while CTG-Leu is more common 
with a long dwell time.  
 
Taken together, there is an early development 
sensitivity to “fast” and “slow” amino acids in the 
ribosome A-site when ribosome levels are transiently 
abundant (Figure 3E). These data strongly indicate 
that the fundamental kinetics of translation shift 
sharply at mid-neurogenesis.  
 
Divergent trajectories of mRNA and protein 
reveal distinct developmental programs of 
neocortex gene expression 
With accumulating evidence that mRNA translation is 
dynamic in neocortex development, we next 
assessed the extent to which protein levels are 
divergent from their corresponding mRNAs. We first 
measured steady state protein levels by MS at each 
stage (Figure S2A), and tested the correlation with 
RNA-seq or Ribo-seq data. Results showed that 
Ribo-seq density is better correlated with protein than 
mRNA levels, for both inter-gene comparisons within 
a sample (Figure S6A) and fold changes over time 
(Figure 4A). Our data in a complex, developing 
tissue reinforce observations of high Ribo-seq:MS 
correlation in cell culture (Fang et al., 2018; 
Jovanovic et al., 2015; Liu et al., 2017). While fold 
changes between adjacent developmental stages 
peaks for steady state mRNA at E15.5, translation 
dynamics persist from E15.5-P0, indicating that mid-
neurogenesis initiates a prolonged period of robust 
translation control (Figure 4A, bottom). 
 
To quantify the variance in protein levels explained 
by steady state mRNA vs. protein synthesis, we 
decomposed technical and systematic variation in 
protein levels, and estimated proportions explained 
by RNA-seq vs. Ribo-seq (Li et al., 2014) (Figures 
4B and S6B). A majority of protein level variance is 
accounted for by RNAseq, in agreement with prior 
observations (Jovanovic et al., 2015; Li et al., 2014). 
However, Ribo-seq consistently explains a higher 
fraction of protein variation than RNA-seq at each 
developmental stage. Proteins whose levels increase 
over time showed a stronger relationship than those 
decreasing – as expected, given the importance of 
degradation rates in determining decreasing protein 
levels. The protein level predictivity of Ribo-seq was 
particularly pronounced for genes with changing 
translation efficiency. 
 
As gene expression trajectory over time is indicative 
of coordinated developmental programs, we next 
performed hierarchical clustering of mRNA and 
protein expression trajectories after E12.5 per gene, 
which divided the proteome into 13 broad clusters 
(Figure 4C and Table S4). We found clusters 
representing concordant and divergent trajectories 
between mRNA and protein, with neural stem cell 
and differentiation markers segregating in distinct 
clusters. While translation efficiency up and down 
genes were found in all clusters, they were enriched 
in clusters demonstrating highly divergent mRNA and 
protein expression trajectory (Figure 4D). 
Reinforcing the biological significance of clusters 
representing different mRNA and protein trajectories, 
gene ontology analysis demonstrated largely non-
overlapping, distinct pathways enriched in different 
clusters, such as neuron differentiation processes 
enriched in cluster D (Figure 4E). Therefore, 
measurement of the translatome by Ribo-seq 
captures important gene expression regulation, with 
mRNA and protein levels frequently divergent in 
neocortex development.   
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Figure 4. Divergent trajectories of mRNA and protein expression by translation regulation in neocortex development. 
(A) Correlation of MS and RNA-seq or Ribo-seq fold changes (FC) between adjacent developmental stages. (B) The percent 
variance in MS explained by RNA-seq or Ribo-seq at each developmental stage, and for subgroups with MS and translation 
efficiency (TE) changes. (C) Hierarchical clustering based on mRNA (RNA-seq) and protein (MS) expression trajectories per 
gene. Fold change expression increasing or decreasing from E12.5 (t0) to subsequent developmental stages (t) shown in heat 
map. Neural stem cell and neuronal marker genes are indicated (right). (D) Expression trajectories of mRNA and protein for 
each cluster in (C), with black lines denoting the median trajectory for each cluster, and grey intervals the upper and lower 
quartiles (left). Enrichment and proportion of TE up and down genes in each cluster (right), with significant enrichment 
annotated *p < 0.05. (E) GO enrichment (biological process, BP) for each cluster, with unique terms for a cluster outlined in 
grey. The top six most significant unique terms per cluster are shown. See also Figure S6. 
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Differential translation of Satb2 results in 
developmental uncoupling of its mRNA and 
protein expression 
Among the most differentially translated 
neurodevelopmental genes discovered in our data is 
Satb2, a chromatin binding protein essential for the 
late-stage formation of neocortex upper layers 
(Alcamo et al., 2008; Britanova et al., 2008), which 
undergoes translation upregulation during 
development (Figure 1D-E). We next assessed the 
developmental expression trajectory of Satb2 in our 
RNA-seq, Ribo-seq, and MS data, in addition to 
translation efficiency (Figure 5A). We compared 
Satb2 expression patterns with the pan-neural stem 
cell marker Nes (Frederikson and McKay, 1988), and 
early-stage lower layer neuron differentiation marker 
Bcl11b (Arlotta et al., 2005) that is expressed in a 
population of cells adjacent to the Satb2 lineage. As 
expected, Nes demonstrates predominantly 
transcriptionally driven expression downregulation, 
as the neural stem cell pool is depleted by 
progressive neuronal differentiation. Bcl11b is 
expressed in the early-born lineage with high 
concordance between RNA-seq and Ribo-seq, and 
with low fluctuation in translation efficiency. In 
contrast, fold changes in Satb2 Ribo-seq and MS 
signal are in excess of the RNA-seq, with 2-fold 
translation efficiency upregulation reaching a plateau 
at E15.5. These data suggest that Satb2 expression 
is amplified by translation. 
 
Since Satb2 mRNA may undergo translation 
regulation, we next examined the cellular distribution 
of Satb2 mRNA in comparison to the expected 
protein expression in later born upper layer neurons 
as reported previously (Alcamo et al., 2008; 
Britanova et al., 2008). Analysis of scRNA-seq data 
(Telley et al., 2019) revealed, unexpectedly, that 
Satb2 mRNA is robustly expressed in differentiated 
neurons of both the early- and late-born lineage 
(Figure 5A, right). Thus, transcription of this upper 
layer program may occur in neuronal lineages that 
include lower layers, and outside of the expected 
protein distribution.                 
 
To directly visualize the expression of Satb2 mRNA 
and protein, we performed fluorescence in situ 
hybridization and immunohistochemistry in 
neocortical coronal sections (Figure 5B), with probe 
and antibody specificity confirmed in Satb2-/- brains 
(Figure S7A), and signal quantified per cell (Figures 
5C and S7B). Unexpectedly, at the onset of 
neurogenesis E12.5, we detected robust Satb2 
mRNA signal throughout the neocortex, with mRNA 
clusters present from the ventricular zone in 
multipotent progenitors and throughout the nascent 
cortical plate in early-born neurons. Satb2 protein 
was undetectable at this stage, whereas weak 
Bcl11b protein signal matched its cortical plate-
localized mRNA signal. Notably, almost half of all 
Satb2 mRNA clusters colocalize with Bcl11b mRNA 
puncta in the cortical plate, but rarely in the 
ventricular zone.  
 
At E14.5, when progenitors begin to yield upper layer 
neurons, Satb2 mRNA is predominantly in cells 
migrating towards the cortical plate, where weak 
Satb2 protein begins to appear. By E16.5, when 
newly born upper layer neurons are migrating 
through the previously formed lower layers, Satb2 
mRNA and protein are broadly expressed across 
upper layers, lower layers, and the intermediate zone. 
However, upper layer neurons almost exclusively 
express Satb2 rather than Bcl11b protein, and 
protein colocalization is minimal in lower layers 
despite the intermixing of migrating cells in this 
region. In the intermediate zone, Satb2 and Bcl11b 
proteins remain co-expressed similar to the mRNA, 
as cells continue to migrate towards the cortical plate.  
 
Thus, in contrast to Bcl11b in the adjacent lower 
layers, Satb2 mRNA and protein expression are 
divergent in developmental time and space. This 
divergence includes broad, early Satb2 mRNA 
expression despite Satb2 protein ultimately restricted 
to upper layers later in development. Furthermore, 
while the distribution and colocalization of mRNA for 
Bcl11b and Satb2 neuronal programs remains broad 
and overlapping at E16.5, corresponding protein 
expression is more exclusive, with the intermediate 
zone a transitory region where specification at both 
the mRNA and protein levels are still lacking 
distinction.  
 
Satb2 is transcribed in the earliest neuronal 
lineages of the developing neocortex 
Given the unexpected finding of Satb2 mRNA in 
early-born neural stem cells, we next sought to 
monitor transcriptional activation of the Satb2 locus, 
and employed a fate mapping approach with the 
Satb2Cre/+ mouse line (Ambrozkiewicz et al., 2017). A 
Cre expression cassette is located in place of exon 2 
at the Satb2 locus, which allows for timed in utero 
electroporation of Cre-inducible reporters like loxP-
STOP-loxP-tdTomato that clonally labels cells with 
tdTomato that have a history of Satb2 transcription 
(Satb2tdTom) (Figure 6A). Co-electroporation with an 
eGFP plasmid serves as a generic label for all 
transfected cells. 
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Figure 5. Satb2 mRNA and protein expression are 
spatiotemporally uncoupled. 
(A) The trajectory of Nes, Bcl11b, and Satb2 gene 
expression measured by RNA-seq, Ribo-seq, MS, and 
translation efficiency (TE) in addition to scRNA-seq. 
scRNA-seq data track differentiating neocortex cells at 1, 
24, or 96 hours after birth (y-axis), at birthdates E12, E13, 
E14, or E15 (x-axis) (Telley et al., 2019). Expected 
distribution of protein expression is outlined. (B) 
Neocortex coronal sections at E12.5, E14.5, and E16.5 
analyzed for Satb2 and Bcl11b mRNA by fluorescence in 
situ hybridization, and protein by immunohistochemistry. 
DAPI (nuclei). Ventricular zone (VZ), cortical plate (CP), 
lower layers (LL), upper layers (UL). (C) Quantification of 
(B). Mean ± SEM. See also Figure S7. 
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Neocortical neuronal progenitors were transfected by 
in utero electroporation at E12.5, E13.5, and E14.5 
with a mixture of loxP-STOP-loxP-tdTomato and 
eGFP, followed by expression analysis after 24 hours 
(Figure 6B). Remarkably, we detected Satb2tdTom 
cells in the ventricular zone at E12.5 forming clusters 
resembling clones or undergoing mitotic divisions. 
Satb2tdTom cells expressed neural progenitor markers 
like Pax6 (apical progenitors) or Tbr2 (intermediate 
progenitors) (Figure 6C). Satb2 transcription was 
observed for progenitors in the neocortex, but not in 
the ganglionic eminence (Figure S8). Thus, early 
Satb2 transcriptional priming occurs in early-born 
neocortex neural stem cells. 
 
Lower layer Bcl11b neurons have a history of 
transcribing the upper layer determinant Satb2  
Satb2 directly suppresses the Bcl11b enhancer in a 
DNA sequence-dependent manner, and loss of 
Satb2 engenders ectopic expression of the 
corticospinal tract determinant Bcl11b in upper layer 
neurons (Britanova et al., 2008). In specific brain 
regions and developmental stages, a distinct 
population of double positive Satb2+/Bcl11b+ 
neurons determines a subset of long-distance sub- 
and cortico-cortical projections (Cederquist et al., 
2013; Harb et al., 2016; Nowakowski et al., 2017); 
however, the origin of these neurons remains unclear.  
 
Given the finding that Satb2 and Bcl11b mRNA co-
expression occurs as early as E12.5 in the cortical 
plate, we then investigated the transcription of Satb2 
in Bcl11b-expressing cells. Satb2tdTom cells with in 
utero electroporation at E12.5 were analyzed at 
E14.5 by immunohistochemistry for neuronal markers 
followed by quantification (Figure 6D-E). At E14.5, 
approximately 35% of E12.5-electroporated cells 
have activated Satb2 during their development. 
Among these Satb2tdTom cells, ~70% express Cre and 
Satb2 protein, and 30% express Bcl11b protein. 
Importantly, the Cre expression pattern matches that 
of native Satb2, with small differences likely 
attributable to antibody efficiency. The observation of 
robust Bcl11b expression in neurons with a history of 
Satb2 transcription suggests that additional layers of 
regulation may be necessary to restrict specification 
of Satb2 or Bcl11b lineages. 
 
Pum2 represses premature Satb2 mRNA 
translation and precocious upper layer 
specification  
With an abundance of ribosomes (Figure 1G-H) and 
Satb2 mRNA (Figure 5B-C) in the ventricular zone 
and cortical plate at E12.5 despite minimal Satb2 
protein translation, we next searched for regulatory 
mechanisms controlling delayed Satb2 mRNA 
translation during early transcriptional priming. Strong 
post-transcriptional regulation is mediated during 
neurodevelopment by differentially expressed RNA-
binding proteins and their binding sites in mRNA 5’- 
and 3’-untranslated regions (UTRs) (DeBoer et al., 
2013; Lennox et al., 2018; Zahr et al., 2019). We first 
asked whether 5’- or 3’-UTR elements are associated 
with translation efficiency upregulation, as measured 
for Satb2 (Figure 5A). UTR length correlates with the 
availability of regulatory binding sites, and hence we 
took an unbiased approach assessing the degree to 
which 5’- and 3’-UTR length is associated with 
translation efficiency up or downregulation across all 
measured genes (Figure 7A). While increasing UTR 
length is associated with increased translation in both 
cases, the 3’-UTR demonstrates a particularly strong 
association with translation upregulation.      
 
We next asked whether known sequence motifs are 
highly represented in the UTRs of translation 
efficiency up and down genes, which may serve as 
binding sequences for neocortical RNA-binding 
proteins (Figure 7B). We found that the 3’-UTRs of 
translation upregulated mRNAs are enriched for 
Pumilio (Pum) RNA-binding motifs. In contrast, 
translation downregulated mRNAs did not display 
any enriched 3’-UTR motifs. Pumilio RNA-binding 
proteins are known translation repressors, influencing 
some neocortical transcripts like the lower layer 
specifier Tle4, preventing prolonged Tle4 protein 
expression later in neurogenesis (Zahr et al., 2018). 
An RNA cross-linking immunoprecipitation screen in 
the brain detected direct interactions between Pum2 
(but not Pum1) and the Satb2 3’-UTR, while no Pum2 
interactions were detected with Bcl11b mRNA 
(Zhang et al., 2017). Whether Pum2 acts early in 
neurogenesis to repress Satb2 specification before 
upper layer formation is unknown. 
 
There are two candidate Pum2 binding motifs in the 
Satb2 3’-UTR (Figure 7C). Just prior to the onset of 
rapid Satb2 translation, we found Pum2 expression is 
decreasing by immunohistochemistry (Figure 7D) 
and MS (Figure 7E). At E12.5, early-born neural 
stem cells in the ventricular zone express high levels 
of Pum2. At E14.5, stem cells beginning the 
transition to upper layer neurogenesis express low 
levels of Pum2, while the early-born lineage in 
nascent lower layers retains the previously high 
expression. We hypothesized that the divergent 
expression patterns of Satb2 and Pum2 may reflect a 
gradually decreasing repression of early Satb2 
translation by Pum2. 
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Figure 6. Satb2 transcription is activated broadly in early- and late-born neural stem cell lineages. 
(A) Schematic of the experimental approach. (B) Satb2 transcription activity visualized by Cre-driven (Satb2Cre/+) tdTomato 
expression, with reporter in utero electroporation (IUE) at E12.5, E13.5, or E14.5 and imaged after 24 hours. Co-electroporation 
of an eGFP plasmid labels all transfected cells. Ventricular zone (VZ), subventricular zone (SVZ). (C) Satb2tdTom co-
immunolabeling with Pax6 (apical progenitors), Tbr2 (intermediate progenitors), and Draq5 (nuclei). (D) Satb2tdTom expression 
at E12.5-E14.5, with co-immunolabeling for neuronal fate determinant proteins Satb2 and Bcl11b, among all electroporated 
cells (eGFP). Negative control is the absence of Cre (Satb2+/+). (E) Quantification of (D) for the expression of Cre, Satb2, and 
Bcl11b proteins in cells transcribing Satb2 mRNA (Satb2 tdTom). Mean ± SD, unpaired t-test, ***p < 0.0001. See also Figure S8. 
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To test the effect of Pum2 on Satb2 and Bcl11b 
protein expression, we performed Pum2 shRNA 
knockdown in ventricular zone progenitors by in utero 
electroporation at E13.5, followed by 
immunohistochemistry assessment of protein 
expression at E15.5 (Figure 7F). Pum2 knockdown 
in early progenitors leads to an increase in the 
fraction of Satb2-positive neurons at E15.5 compared 
to scrambled control, while Bcl11b expression is 
unaffected (Figure 7G). These data suggest that 
Pum2 represses Satb2 mRNA translation during 
neocortical development, restricting Satb2 
specification until upper layer formation, despite 
widespread Satb2 transcription.      
 
DISCUSSION 
Our study traces how functional gene expression is 
catalyzed in a complex developmental system, 
capturing the reactants, synthesis, and products of 
mRNA translation across the time course of 
neocortex neurogenesis (https://shiny.mdc-
berlin.de/cortexomics/). During the transition from a 
stem cell predominant early development tissue 
towards a differentiated neuronal tissue, the level of 
the translation machinery itself is highly dynamic, 
with an acute decline in ribosome number at mid-
neurogenesis. The transition from relative ribosome 
abundance to depletion is accompanied by a 
chronological shift in translation kinetics, where N-
terminal codons are translated more slowly, and 
variations in codon dwell time during elongation – 
arising from specific amino acids in the A-site – 
equalize. We estimate ~18% of the neocortex 
transcriptome undergoes translation efficiency 
changes, leading to uncoupling in developmental 
space and time of transcription and translation. 
Dynamic regulation of the translatome impacts 
functional gene expression, with mRNA and protein 
levels frequently divergent, impacting essential 
neuronal fate determinants like Satb2. Neural stem 
cells harbor a pool of mRNAs broadly inclusive of 
diverse neuronal fates, which is filtered at the protein 
level to refine neuronal specification, and sharply 
demarcate cellular boundaries patterning the 
neocortex.                      
 
The overwhelming influence that changes in 
ribosome number can have on global protein 
synthesis kinetics and mRNA-specific translation is 
strongly supported by theoretical and experimental 
data, and leads to “ribosomopathies” in disease 
states (Mills and Green, 2017; Shah et al., 2013). 
The global decrease in ribosome number per cell in 
the cortical plate represents a coordinated change in 
ribosomal protein synthesis occurring at the level of 
translation. Developmentally timed signals may 
initiate highly orchestrated translation regulation 
(Kraushar et al., 2021), such as secreted 
extracellular factors (Kraushar et al., 2015). Global 
shifts in ribosome levels were recently appreciated to 
be highly impactful in neurodevelopmental 
pathologies originating in pregnancy (Kalish et al., 
2021), and is an interesting direction for future 
investigation.   
 
By leveraging the single nucleotide resolution of 
Ribo-seq, we gain insights into the fundamental 
nature of translation in the developing brain. In our 
cycloheximide-free data, we find a position-specific 
developmental shift in the distribution of ribosome 
density surrounding both the start and stop codons. 
Previous studies of the “5’ ramp” present in Ribo-seq 
experiments have proposed that it represents ‘slow’ 
synonymous codon choice near the coding sequence 
start – an adaptation to prevent ribosome collision 
further into the open reading frame (Pechmann and 
Frydman, 2013). Our data argue against this as the 
sole mechanism of 5’ ramping, since numerous 
genes show an increase in start density despite the 
generally decreasing effect of codon choice. The 
increasing relative density at the 5’ of many mRNA 
coding sequences resembles what might be 
expected during a shift from ribosome abundant 
elongation-limited to ribosome scarce initiation-
limited translation (Heyer and Moore, 2016), when 
kinetic barriers to start codon initiation and elongation 
of early N-terminal peptides (Verma et al., 2019) 
become comparatively prominent. Of note, we do not 
observe increasing start codon density only for high 
translation efficiency genes, or correlation with 
neurite-localized translation (Figure S2E-F). We 
therefore favor the hypothesis that ribosome 
occupancy at beginning of open reading frames 
becomes progressively rate-limiting for codon-
independent reasons, such as scarcity of translation 
cofactors and the ribosome itself.  
 
To our knowledge, our study is the first to 
demonstrate differences in the fundamental nature of 
codon-specific ribosome density over developmental 
time. Our study agrees with previous work (Gingold 
et al., 2014; Ingolia et al., 2011) that suggest tRNA 
levels are not a limiting factor for translation 
elongation in mammals, as they are in exponentially 
dividing yeast. Notably, however, these findings do 
not rule individual cases where a tRNA may influence 
ribosome stalling, as reported for one nervous 
system-specific tRNA postnatally (Ishimura et al., 
2014). We find that the A-site amino acid strongly 
influences translation speed, suggesting that factors 
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Figure 7. Pumilio2 represses the expression of Satb2 protein in the early-born lineage to refine upper layer specification. 
(A) The cumulative fraction of mRNAs across all stages with increasing, decreasing, or no change in translation efficiency (TE) 
as a function of 5’ and 3’-UTR length. (B) Positional weight matrix of the top two motifs ranked by p-value in the 5’ and 3’-UTRs 
of TE up or down mRNAs (across all stages). “TEsig” and “non” refer to the percentage of genes containing the motif among 
significantly changing TE sequences, and non-changing length-matched controls, respectively. (C) Developmental RNA-seq, 
Ribo-seq, and MS signal aligned to Satb2 isoforms, including the position of Pumilio2 (Pum2) binding motifs. (D) Neocortex Pum2 
protein expression (heat) at E12.5 and E14.5 measured by immunohistochemistry. (E) Developmental protein expression 
trajectory of Satb2 and Pum2 measured by MS. (F) shRNA knockdown of Pum2 compared to scrambled control by in utero 
electroporation (IUE) at E13.5 followed by analysis at E15.5 with Satb2 and Bcl11b immunolabeling. Co-electroporation of eGFP 
labels all transfected cells. (G) Quantification of (F) for the percent of electroporated cells expressing Satb2 and/or Bcl11b protein. 
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like the electrostatics of peptidyl chain elongation 
(Chadani et al., 2017; Riba et al., 2019), amino acid 
availability, and/or tRNA aminoacylation might play a 
more important role in early brain development. 
Directly measuring tRNA charging or the intrauterine 
metabolic level of amino acids would further address 
such questions directly, and are interesting directions 
for future study. 
 
We measure substantial divergence of mRNA and 
protein expression for distinct neurodevelopmental 
programs. Broad co-existence of Satb2 and Bcl11b 
mRNA in the same cell, with co-expression more 
restricted at the protein level, is indicative of multi-
level gene expression regulation during stem cell 
differentiation. Why would neuronal differentiation 
benefit from broad transcription of a more “generic” 
mRNA pool (Telley et al., 2019), followed by selective 
translation? We speculate that such a mechanism 
affords the opportunity for tightly timed, rapidly 
scalable, and spatially targeted gene expression to 
assemble highly evolved, complex circuits. Per gene 
per hour, translation is faster and more scalable than 
transcription by orders of magnitude (Schwanhäusser 
et al., 2009), and neuronal specification transitions 
occur in very narrow developmental windows. The 
availability of a diverse repertoire of both lower and 
upper layer associated mRNAs like Bcl11b and 
Satb2, respectively, which can be rapidly and 
selectively amplified at the protein level, may be 
essential to specify Bcl11b- or Satb2-exclusive 
neurons, in addition to Bcl11b-Satb2 double-positive 
neurons (Nowakowski et al., 2017).  
 
Thus, our data and previous reports (Srinivasan et al., 
2012; Zahr et al., 2018) indicate that genetic 
programs utilized in the developing cortex to specify 
upper layers are inherently intertwined with ones that 
give rise to deep layers, and rely on a tight 
spatiotemporal translational control, rather than a 
simple sequence of transcriptional regulation. Upper 
neocortical layers expanded evolutionarily to support 
higher associative connectivity and function, on top of 
the more evolutionarily ancient lower layers, and thus 
might include remnants of lower layer gene 
expression programs that are modulated post-
transcriptionally. We find that the translation 
repressor Pum2, highly expressed in early rather 
than late born neural stem cells, helps restrict the 
production of Satb2-positive neurons to the late-born 
upper layer lineage. Our study thus joins an evolving 
body of work on RNA-binding proteins like the Elav 
(Kraushar et al., 2014; Popovitchenko et al., 2020) 
and Pumilio (Zahr et al., 2018; Zhang et al., 2017) 
families that regulate ribosome-mRNA interactions, in 
addition to direct ribosome binders (Kraushar et al., 
2021) in the developing neocortex.  
 
Taken together, our data suggests a model of gene 
expression where the fundamental levels and kinetics 
of translation shift during key developmental windows 
of neocortex neurogenesis, with mid-neurogenesis a 
major inflection point (Figure 7H). These 
developmental windows correspond to timed 
changes in neuronal specification from neural stem 
cells, where broad transcription of neuronal subtype-
specific programs is ultimately refined by translational 
control, more precisely demarcating the boundaries 
of neuronal circuits in the neocortex.   
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STAR★METHODS 
KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies   
Goat anti-GFP Rockland 600-101-215M; RRID:AB_2612804 
Rabbit anti-Pax6 Millipore AB2237; RRID:AB_1587367 
Rabbit anti-Tbr2 / Eomes Abcam ab23345; RRID:AB_778267 
Rabbit anti-Satb2 (Ambrozkiewicz et al., 2017) N/A 
Rat anti-Bcl11b (Ctip2) Abcam 25B6; RRID:AB_2064130 
Rabbit anti-Cre Synaptic Systems 257003; RRID:AB_2619968 
Donkey anti-goat AlexaFluor-488 Jackson Immunoresearch 705-546-147; RRID:AB_2340430 
Donkey anti-rabbit AlexaFluor-488 Jackson Immunoresearch 711-545-152; RRID:AB_2313584 
Donkey anti-rabbit AlexaFluor-Cy3 Jackson Immunoresearch 711-167-003; RRID:AB_2340606 
Donkey anti-rabbit AlexaFluor-Cy3 Jackson Immunoresearch 711-165-152; RRID:AB_2307443 
Mouse anti-Rps5 (uS7) Santa Cruz sc-390935; RRID:AB_2713966 
Rabbit anti-Rpl24 (eL24) Abcam ab126172; RRID:AB_11127305 
Rabbit anti-Pum2 Abcam ab92390; RRID:AB_10563318 
Gold-conjugated-anti-mouse IgG Nanoprobes 2001; RRID:AB_2877644 
 
FISH Probes   
RNAscope Probe-Mm-Satb2 ACD, Bio-techne 413261 
RNAscope Probe-Mm-Bcl11b-C2 ACD, Bio-techne 413271-C2 
 
Recombinant DNA   
pCAG-eGFP (Ambrozkiewicz et al., 2017) N/A 
pCAG-flox-STOP-flox-tdTomato (Ambrozkiewicz et al., 2017) N/A 
pLKO.1-Scrambled control Thermo Scientific (Ambrozkiewicz et al., 2017) N/A 
pLKO.1-sh-Pum2 Sigma Mission TRCN0000233377 
 
Chemicals, Peptides, and 
Recombinant Proteins 
  
Acetonitrile  CHEMSOLUTE 2697 
Agarose Sigma-Aldrich A9539 
Ammonium bicarbonate (ABC) Sigma-Aldrich 9830 
Bovine serum albumin  Sigma-Aldrich A3294 
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DAPI (Nuc Blue, Molecular Probes) Invitrogen R37606 
Dithiothreitol (DTT) Sigma-Aldrich/Roche DTT-RO 
DNAse-I Roche 4716728001 
Ethanol J.T. Baker 8025 
Fetal Bovine Serum Gibco 10270106 
Formic acid Sigma-Aldrich 33015 
HEPES Sigma-Aldrich 391338 
IGEPAL CA-630 Sigma-Aldrich I8896 
Iodoacetamide (IAA) Sigma-Aldrich I6125 
KCl Roth 6781.1 
Lysyl endopeptidase (LysC) Wako 12505061 
Methanol Merck Millipore 1.06009.2511 
MgCl2 Ambion AM9530G 
Normal goat serum  PAN-Biotech P30-1002 
Paraformaldehye (PFA) Sigma-Aldrich P6148 
Phenylmethyl sulphonyl fluoride 
(PMSF) Roth 6367 
Protease Inhibitor cOmplete EDTA-
free  Roche 5056489001 
ReproSil-Pur C18-AQ 3-μm resin Dr. Maisch GmbH r13.aq 
RNasin Plus RNAse inhibitor  Promega N2615 
RNAse-T1 Thermo Fisher eno541 
RNAse-A Thermo Fisher eno531 
Sodium dodecyl sulfate (SDS) Roth 2326.1 
Spermidine3HCl Sigma-Aldrich S2501 
Spermine4HCl Sigma-Aldrich S2876 
Sucrose Sigma-Aldrich S0389 
SUPERase-In RNAse inhibitor  ThermoFisher AM2694 
Tris-HCl Roth 9090.3 
Triton-X 100 Sigma-Aldrich T8787 
TRIzol-LS Invitrogen 10296010 
Trypsin  Promega V511A 
TurboDNase Thermo Fisher AM2238 
Tween Sigma-Aldrich P9416 
Urea Sigma-Aldrich 51459 
Vectashield Mounting Medium Vector Laboratories H-1000 
 
Critical Commercial Assays   
NEBNext Ultra Directional RNA 
Library Prep Kit for Illumina New England BioLabs E7420L 
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NEXTflex Small RNA-seq Kit v3 Bio Scientific NOVA-5132-06 
RNA Clean & Concentrator-25 Kit Zymo Research R1017 
RiboZero Kit Illumina 20037135 
TruSeq Stranded mRNA Kit  Illumina 20020594 
Zymoclean Gel DNA Recovery Kit Zymo Research D4007/D4008 
RNAscope Multiplex Fluorescent 
Reagent Kit v2 ACD, Bio-techne 323100 
 
Deposited Data   
Neocortex Ribosome Profiling this paper NIH GEO: GSE169457  
Neocortex RNA-seq (Kraushar et al., 2021) NIH GEO: GSE157425 
Neocortex tRNA qPCR Array this paper NIH GEO: GSE169621  





CD1 WT mice Charles River RRID:IMSR_CRL:22 
NMRI WT mice Charles River and Janvier Labs RRID:IMSR_TAC:nmri 
Satb2Cre/+ mouse line (Britanova et al., 2008) N/A 
 
Software and Algorithms   
Bcl2fastq https://support.illumina.com/downloads/bcl2fastq-conversion-software-v2-20.html 2.20.0 
Bowtie2 (Langmead and Salzberg, 2012)  
Cutadapt (Martin, 2011)  
FIJI (Schindelin et al., 2012) https://fiji.sc/  
GraphPad Prism 7 GraphPad Software Inc. https://www.graphpad.com/  
Gviz (Hahne and Ivanek, 2016)  
IBAQ (Schwanhäusser et al., 2011)  
Illustrator Adobe Creative Cloud  
LFQ (Cox et al., 2014)  
Limma (Law et al., 2014)  
MaxQuant (Cox and Mann, 2008)  
Meme McLeay & Bailey, 2010  
Perseus (Tyanova et al., 2016)  
Photoshop Adobe Creative Cloud  
proDA https://github.com/const-ae/proDA   
R v4.0.0 https://www.r-project.org/  
RiboDiPA (Li et al., 2020)  
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Ribo-seqC v1.1 https://github.com/ohlerlab/Ribo-seqC  
snakemake https://academic.oup.com/bioinformatics/article/28/19/2520/290322   
SPSS v.17 IBM Inc. 	
STAR (Dobin et al., 2013) 	
topGO https://bioconductor.org/packages/release/bioc/html/topGO.html  	
TopHat2 (Kim et al., 2013)  
tximport https://f1000research.com/articles/4-1521/v1  
Xtail (Xiao et al., 2016)  
 
CONTACT FOR REAGENT AND RESOURCE SHARING 
Lead Contact 




This study did not generate new unique reagents. 
 
Data and Code Availability 
Code generated during this study, not otherwise referenced in the Methods, is supplied at 
https://github.com/ohlerlab/cortexomics. Further requests may be directed to and will be fulfilled by the Lead 
Contact, matthew.kraushar@molgen.mpg.de (M.L.K.). Data have been deposited in publicly available 
repositories as indicated in the Methods.  
 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 
Mice 
Mouse (Mus musculus) lines were maintained in the animal facilities of the Charité University Hospital and 
Lobachevsky State University. All experiments were performed in compliance with the guidelines for the 
welfare of experimental animals approved by the State Office for Health and Social Affairs, Council in Berlin, 
Landesamt für Gesundheit und Soziales (LaGeSo), permissions T0267/15, G0079/11, G206/16, and G54/19, 
and by the Ethical Committee of the Lobachevsky State University of Nizhny Novgorod. Mice were utilized in 
the embryonic (E12.5-E17) and early post-natal (P0) period, inclusive of both male and female sexes in each 
litter without distinction. Timed pregnant wild-type (WT) CD-1 mice utilized for Ribo-seq, RNA-seq, tRNA qPCR 
array, mass spectrometry, and immuno-electron microscopy were obtained from the Charles River Company 
(Protocol: T0267/15). Experiments with fluorescent in situ hybridization and immunohistochemistry (Figures 5, 
7, and S7) were performed in NMRI WT mice. For experiments with the tdTomato reporter (Figures 6 and S8), 
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Satb2Cre/+ males (Britanova et al., 2008) were mated to NMRI wild type females (Protocols: G0079/11, G54/19, 
and G206/16). Satb2Cre/+ mouse genotyping was performed as described (Britanova et al., 2008). 
 
METHOD DETAILS 
Neocortex sample preparation for bioinformatics analysis 
Dissection, cryogenic lysis, and determination of optical density units (ODU) were performed as described 
(Kraushar et al., 2021).  
 
Ribo-seq and RNA-seq sample preparation and sequencing 
Each replicate for paired neocortex Ribo-seq and RNA-seq included 40 brains (80 hemispheres) at E12.5, 30 
brains (60 hemispheres) at E14, 21 brains (42 hemispheres) at E15.5, 20 brains (40 hemispheres) at E17, and 
17 brains (34 hemispheres) at P0 – performed in biological duplicate at each stage. Neocortex tissue was 
lysed on ice in 20 mM HEPES, 100 mM KCl, 7.5 mM MgCl2, pH 7.4, supplemented with 20 mM Dithiothreitol 
(DTT), 0.04 mM Spermine, 0.5 mM Spermidine, 1x Protease Inhibitor cOmplete EDTA-free (Roche, 
05056489001), 0.3% v/v IGEPAL CA-630 detergent (Sigma, I8896) and clarified by centrifugation at 16100 xg 
for 5 min at 4 °C with a benchtop centrifuge. Samples were then measured for A260 ODU on a NanoDrop 
1000 Spectrophotometer. Two thirds of the sample were transferred to a new tube for Ribo-seq preparation, 
with the remaining one third for RNA-seq was mixed with 100 U SUPERase-In RNAse inhibitor (ThermoFisher, 
AM2694) and frozen at -80 °C for downstream RNA isolation.  
 
For digestion of ribosome protected RNA fragments (RPFs), Ribo-seq samples were then mixed with 60U 
RNAse-T1 plus 96 ng RNAse-A per ODU (as optimized, Figure S1A-B), and incubated for 30 min at 25 °C, 
shaking at 400 rpm. To stop RNAse activity, 200 U of SUPERase-In RNAse inhibitor was then added.  
 
10-50 % 5 mL sucrose density gradients were prepared in Beckman Coulter Ultra-Clear Tubes (344057). Base 
buffer consisted of 20 mM HEPES, 100 mM KCl, 10 mM MgCl2, 20 mM Dithiothreitol (DTT), 0.04 mM 
Spermine, 0.5 mM Spermidine, 1x Protease Inhibitor cOmplete EDTA-free (Roche, 05056489001), 20 U/mL 
SUPERase-In RNAse inhibitor (ThermoFisher, AM2694), pH 7.4, prepared with 10 & 50 % sucrose w/v. 
Overlaid 10 & 50 % sucrose-buffer solutions were mixed to linearized gradients with a BioComp Gradient 
Master 107ip.  
 
Digested lysates were overlaid on gradients pre-cooled to 4 °C. Gradients were centrifuged in a SW55 rotor 
(Beckman Coulter) for 1 hr, 4 °C, 37000 rpm, and fractionated using a BioComp Piston Gradient Fractionator 
and Pharmacia LKB SuperFrac, with real-time A260 measurement by an LKB 22238 Uvicord SII UV detector 
recorded using an ADC-16 PicoLogger and associated PicoLogger software. Fractions corresponding digested 
80S monosomes (Figure S1C) were pooled and stored at -80 °C.  
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RNA isolation with TRIzol LS was then performed for both RNA-seq and Ribo-seq samples, as per the 
manufacturer’s instructions. For Ribo-seq and RNA-seq samples, downstream library preparation and 
sequencing were performed as described (Kraushar et al., 2021). RNA-seq data were utilized in a recent study 
(Kraushar et al., 2021) corresponding to NIH GEO entry GSE157425. Ribo-seq data in this study are deposited 
in the NIH GEO: GSE169457. 
 
Mass spectrometry sample preparation 
Total proteome analysis from neocortex lysates at E12.5, E14, E15.5, E17, and P0, including complete lysis in 
RIPA buffer, and downstream processing for mass spectrometry analysis, was performed in a recent study 
(Kraushar et al., 2021) corresponding to ProteomeXchange entry PXD014841. 
 
tRNA qPCR array sample preparation and measurement 
tRNA qPCR array measurement of 151 tRNA isodecoders was performed by Arraystar (Maryland, USA) for 
neocortex lysates at E12.5, E14, E15.5, E17, and P0 from the same total RNA isolated for RNA-seq described 
above. Data are deposited in the NIH GEO: GSE169621. 
      
Ribo-seq and RNA-seq data processing 
Raw sequence data was converted to FASTQ format using bcl2fastq. Adapters (sequence 
TGGAATTCTCGGGTGCCAAGG) were removed from Ribo-seq reads with cutadapt, as well as sequences 
with a quality score less than 20 or a remaining sequence length less than 12, and after removing duplicate 
read sequences, 4bp UMIs were trimmed from either end of each sequence using a custom perl script. Ribo-
seq reads were then aligned to an index of common contaminants (including tRNA, rRNA, and snoRNA 
sequences) using bowtie2. The resulting processed read files were then aligned to coding sequences (the 
pc_transcripts fasta file), and separately, to the genome, from GENCODE release M12 (Mus musculus) using 
STAR, with the following settings: STAR     --outSAMmode NoQS --outSAMattributes NH NM --
seedSearchLmax 10   --outFilterMultimapScoreRange 0 --outFilterMultimapNmax 255 --
outFilterMismatchNmax 1 --outFilterIntronMotifs RemoveNoncanonical. RNA-seq and Ribo-seq libraries 
achieved high coverage, with a median of 33M and 12M reads mapped to protein coding transcripts, 
respectively. For quality control, downstream analysis focused on coding sequences with 32 or more Ribo-seq 
footprints in at least one stage as per (Dunn et al., 2013), which resulted in a set of 12,228  translated gencode 
transcripts (Table S1). 
 
Since ribosomes with their A-site over a given position will produce a distribution of read lengths mapping to 
nearby positions, A/P-site alignment represents a crucial step in the processing of Ribo-seq datasets. 
Frequently, algorithms for A-site alignment rely either explicitly (Calviello et al., 2019; Fang et al., 2018) or 
implicitly (Ahmed et al., 2019;) on the presence of large peaks at the start and/or stop codons, the known 
location of which provides a ‘true positive’ that can be used to choose P-site offsets for each read length. We 
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found that such methods gave inconsistent results in our data, with optimal P-sites being chosen at 
biochemically implausible values (e.g., at 0 base pairs from the read 5’-end). This is likely due to 1) the variable 
occupancy of the start/stop peak in our data (Figure 2A-B), and 2) the presence of cut-site bias in our data 
due to the necessity of RNAse T1 & A digestion (Figure S1A-B). Calculating ‘metacodon’ (O’Connor et al., 
2016) plots of RPF 5’-end occurrence showed that the most variation between different codons and time points 
(other than cut-site bias itself at RPF termini) was nonetheless limited to a narrow region a consistent distance 
from the codon, for each read length (Figure S4A-B). Normalizing these profiles to their median value and 
measuring the between-codon variance at each position revealed that it aligned with an offset of approximately 
14-15 nt (consistent with the A-site position), for reads of length between 25 and 31, and so we chose these for 
further analysis of ribosome dwell time (Table S3). We also observed an adjacent region of lesser variability 
3bp towards the RPF 5’ end, consistent with a non-zero but lesser influence of the P-site codon (Table S3). 
Genomic alignments were used for metagene plots and metacodon analyses.  
 
The program DeepShapePrime (Cui et al., 2019), modified to accept our chosen P-site offsets instead of 
hardcoded ones, was then used to derive isoform specific abundance measurements for each protein coding 
transcript. 
 
In parallel to the above, iso-form level quantification of the RNA-seq was carried out using salmon, with an 
index built from coding M12 sequences, and the following settings: salmon quant -l SR --seqBias --
validateMappings 
 
A snakemake file automating the above workflow is available at https://github.com/ohlerlab/cortexomics. 
 
We then converted DeepShape-prime’s output to salmon format to combine both outputs, using the ORF 
length as effective length. The R package tximport was used to derive length-corrected gene-level counts and 
isoform level counts and TPMs for both datasets. The voom package was used for variance stabilization and 
linear modelling of this data to derive confidence intervals for transcriptional and translational change, both 
relative to E12.5, and stepwise between each stage. The xTail package (Xiao et al., 2016), which is specifically 
geared towards estimation of translational efficiency (TE; i.e. the ratio of Ribo-seq density to RNA-seq density)  
change in the presence of transcriptional change, was used to detect changing TE. Numbers for TE change 
quoted in the text refer to xtail’s differential TE calls.  
 
For metagene plots (Figure 2A), a ‘best transcript’ (the transcript with the highest median Ribo-seq coverage 
across all samples) was selected for each gene. These transcripts were further limited to those with a length of 
192 or greater. Each of these transcripts was also also analysed using the RiboDiPA package, which looks for 
position-specific differences in Ribo-seq occupancy between conditions. Since metacodon plots indicated that 
changes at the start and stop codon were limited to a distinct region 3-4 codons from the start and stop, we 
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divided each coding sequence in to 15 bins, with 7 bins of 4 codons each centering on the start and stop, and 
a final ‘mid’ bin of variable size encompassing the rest of the ORF (ORFs too short to accommodate this were 
excluded). We then plotted bin-level log2 fold changes for each gene with significant q-value of using the 
AUG/stop changing bins (Figure 2B). For Figures 1D, 4A, 4C and S6B, linear fold change for RNA-seq and 
Ribo-seq were calculated using limma (Law et al., 2014), TEs were calculated using xtail, and MS fold changes 
were calculated using proDA (Table S2). 
 
Fold changes were binarized into ‘significant’ (absolute fold change greater or less than 1.25, adjusted p-value 
< 0.05) and ‘non-significant’ for up and down regulated genes respectively, for plotting, and GO term analysis – 
referred to as dTE and non-dTE in the case of TE fold-change. For GO term analyses of TE change and 
positional Ribo-seq change, The R package topGO was used.  
 
A list of ribosomal proteins for the mouse large and small subunits were curated from Uniprot. 
 
tRNA abundance and codon dwell time analysis 
tRNA abundance was calculated from Arraystar Ct values by the negative delta Ct value for each tRNA 
compared to the mean of 5S and 18S rRNA levels in each sample (Figure S5). Abundance per-codon was 
calculated by taking the mean of each replicate, and summing values for all relevant iso-decoders. Availability 
(Gobet et al., 2020) was calculated as the residual from a simple linear model regressing codon usage against 
abundance, where codon usage was defined as the occurrence of that codon in the M12 coding transcriptome, 
weighted by the relevant TPM of each transcript in that sample. We attempted weighting by wobble base pairs 
as in (dos Reis et al., 2004) and found this did not impact the conclusions in Figure 3. 
 
Dwell time (Weinberg et al., 2016), for each codon, was defined as the mean occurrence of read 5’ ends at the 
1st base pair of the A-site, for each codon, using the normalized metacodon occupancy profiles (see above 
section on P-site alignment).  
 
Relationships between codon dwell time, tRNA abundance/availability, and amino acid identity, were 
investigated using the R function lm. The dataset used consisted of 269 – (i.e. one per quantified codon, per 
sample) with terms for the stage of the sample (S), the amino acid coded for (AA), and the abundance (or 
availability) of the encoding tRNAs (AB). 
 
The largest explanatory variable was AA, which also showed a significant interaction with S, indicating that the 
amino acid coded for explained ~ 34% of the variance in dwell time between codons. This term also showed a 
significant interaction with sample stage, indicating that the amino-acid specific factors determining dwell time 
may vary over development (e.g., due to the availability of amino acids changing). Within a sample or across 
all samples, there was no association between tRNA abundance and dwell time, even after correcting for the 
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effect of amino acid coded-for. Some codons however show a significant interaction between abundance and 
developmental stage, and because these codons were biased towards the high or low end of the abundance 
dwell time spectrum, we plotted time-relative change vs abundance, for the top and bottom quartiles of dwell 
time abundance. This revealed a significant association between change in time-relative tRNA abundance and 
dwell time, with fastest codons showing decreasing tRNA abundance as they slowed, and the slowest codons 
also showing decreasing tRNA abundance. 
 
Mass Spectrometry data processing 
All raw data were analyzed and processed by MaxQuant (v1.6.0.1) (Cox and Mann, 2008). Default settings 
were kept except that ‘match between runs’ was turned on. Search parameters included two missed cleavage 
sites, cysteine carbamidomethyl fixed modification and variable modifications including methionine oxidation, 
protein N-terminal acetylation and deamidation of glutamine and asparagine. The peptide mass tolerance was 
6ppm and the MS/MS tolerance was 20ppm. Minimal peptide length of 7 amino acids was required. Database 
search was performed with Andromeda (Cox et al., 2011) against the UniProt/SwissProt mouse database 
(downloaded 01/2019) with common serum contaminants and enzyme sequences. The false discovery rate 
(FDR) was set to 1% at peptide spectrum match (PSM) level and at protein level. Protein quantification across 
samples was performed using the label-free quantification (LFQ) algorithm (Cox et al., 2014). A minimum 
peptide count required for LFQ protein quantification was set to two. Only proteins quantified in at least two out 
of the three biological replicates were considered for further analyses. 
 
To improve the match between mass spec data and sequence data, the peptides from each mass spec group 
were matched against M12 protein sequences. Instances in which a UNIPROT gene identifier did not match 
any gene in Gencode, but in which the associated peptide sequences matched proteins for a single Gencode 
gene, were updated to match that Gencode gene. All further analyses were carried out using gene-level 
proteomic data. 
 
The R package proDA was used to calculate dropout-aware abundance estimates for each protein group, as 
well as fold changes and confidence intervals relative to E12.5. For each gene, a ‘best’ matching protein group 
was defined as the one with the least missing, and highest median, signal across all samples, and selected for 
further analysis. 
 
Analysis of variance  
Analysis of variance was carried out a manner similar to (Li et al., 2014). We fit a linear model regressing 
measured protein levels, or protein fold changes, P, against measured Ribo-seq or RNA-seq levels R. We then 
performed variance decomposition using the following equation: 
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We applied this equation both within each time point, and to the fold changes between each time point. 
Stochastic error terms for both within-stage and between stage values for R and P were calculated using 
limma and proDA respectively. Notably, correlation between the two sequencing assays and MS is strongly 
dependent on the magnitude of change at that time point, with technical noise specific to each assay non-
correlated (Buccitelli and Selbach, 2020).  For the R implementation of the above equations, see our github 
repository (https://github.com/ohlerlab/cortexomics), and the file src/Figures/Figure4/2_vardecomp.R. 
 
Hierarchical clustering 
For hierarchical clustering (Table S4), we took fold changes in RNA-seq and MS values relative to E12.5, for 
each gene, and carried out PCA on the resulting n x 8-dimensional matrix. We calculated Euclidean distances 
between genes and performed hierarchical clustering using the R function hclust and the ‘ward’ clustering 
criterion – i.e., favoring the creation of large clusters rather than small clusters containing few outliers. We 
found that our expression data showed a smooth reduction in variance explained as the number of clusters 
varied, and so we plotted GO-term enrichment for different cluster numbers, and finding that clusters with 
similar GO-term enrichments began to appear at a cluster number of 13 chose this as our cutoff. Meta-
trajectories for each cluster were plotted using the median and upper/lower quartiles for each cluster. 
Enrichment of dTE genes in each cluster was calculated using Fisher’s exact test (with dTE status, and 
inclusion in the cluster, as binary variables). GO term analysis of each cluster was carried out using topGO. 
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Single cell RNA-seq data 
Single cell RNA-seq (scRNA-seq) data in Figure 5A was derived from data and scripts in (Telley et al., 2019) 
and accompanying web resource http://genebrowser.unige.ch/telagirdon/#query_the_atlas. For each gene, it’s 
occurrence in neocortex cells measured by scRNA-seq is presented as a heat map arranged by chronological 
time of cell collection (x-axis) vs. time since cell birth (y-axis), after a timed pulse with a FlashTag label in utero. 
These axes correspond to roughly orthogonal programs of gene expression change, with the y-axis describing 
differences between apical progenitors and differentiated neurons, and the x-axis describing differences 
between cells born at different stages of development. 
 
Sequence motif analysis and UTR length analysis 
UTR length in Figure 7A was calculated by taking the longest 5’- or 3’-UTR for each gene. Motif analysis 
(Figure 7B) was carried out using the AME program from the Meme suite as per (Becker et al., 2018; McLeay 
and Bailey, 2010) because we observed a systematic difference in UTR length between TE changing and TE 
unchanging genes. AME requires that input and control sequences are of approximately equal length 
distribution, so we created a sample of TE changing genes whose length distribution matched that of the TE 
unchanging genes. We ran AME with the CISBP-RNA database of RNA-binding protein motifs. Additionally, we 
created PWMs from the Pum1 and Pum2 motifs listed in (Zhang et al., 2017). Locus plots in Figure 7C were 
created using Gviz (Hahne and Ivanek, 2016), and the motifs shown were found using consensus sequences 
from these PWMs. 
 
Immuno-electron microscopy 
Fixation, sectioning, immunolabeling, and electron microscopy were performed as described previously 
(Kraushar et al., 2021). E12.5 and E15.5 neocortex coronal sections were labeled with mouse anti-Rps5 (uS7; 
Santa Cruz, sc-390935) followed by 2.5 nm nanogold conjugated secondary antibody (Nanoprobes, 2001). 
Imaging was performed at 2700 x magnification on a Tecnai Spirit electron microscope. Quantification was 
performed in FIJI (Schindelin et al., 2012) with the Process > Find Maxima tool (as shown in Figure 1G, 
magenta pseudocolor), and Measure > Area tool, followed by statistical analysis in GraphPad Prism 
(GraphPad Software Inc.) to calculate puncta per μm2 (Welch’s ANOVA, Dunnett’s post hoc test). Primary 
antibody leave-out controls were prepared in parallel, and were absent of nanogold signal (Figure S3). 
 
Expression vectors 
For tdTomato reporter experiments, we used beta-actin driven expression constructs pCAG-EGFP and pCAG-
flox-STOP-flox-tdTomato, as described previously (Ambrozkiewicz et al., 2017). A control vector with 
scrambled non-silencing shRNA (Ambrozkiewicz et al., 2018) was obtained from Thermo Scientific. A vector 
encoding an shRNA to knock-down mouse Pum2 was purchased from Sigma Mission (TRCN0000233377), 
sequence:  
5’-CCGGCCTAATCCGACAGCGAATAAACTCGAGTTTATTCGCTGTCGGATTAGGTTTTTG-3’ 
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In utero electroporation (IUE) 
Mouse embryos were subjected to IUE exactly as described previously (Ambrozkiewicz et al., 2017, 2018, 
2020). For the experiments with the tdTomato reporter in the Satb2Cre/+ line, we used an equal amount of 
pCAG-GFP and pCAG-flox-stop-flox-tdTomato. 
 
Fluorescent in situ hybridization (FISH) 
In situ hybridization using RNAscope Technology to detect mRNA of Satb2 and Bcl11b (Figure 5B) was 
performed according to the manufacturer’s protocols (ACD). Prior to hybridization, embryonic brains at E12.5, 
E14.5 and E16.5 were collected in PBS, fixed in 4 % PFA/PBS prepared with DEPC for 16-20 hours at 4 °C. 
Brains were then incubated in sucrose solutions (10 % - 20 % - 30 %/PBS) until they reach osmotic equilibrium, 
embedded in O. C. T. Compound (Tissue-Tek) in a plastic cryoblock mold and frozen on dry ice. Coronal 
sections of 16 μm thickness were collected using a cryostat.  
 
Cryosectioning 
For all histological procedures, brain sections were prepared on a Leica CM3050S cryostat. Prior to 
cryosectioning, brains were incubated for at least 5 hours with 10% sucrose in PBS, followed by incubation 
with 30% sucrose in PBS until the tissue reached osmotic equilibrium. Next, brains were frozen in -38 to -40°C 
isopentane (Roth). For processing of the tissue after in utero electroporation, coronal cryosections of 50 μm 
thickness were collected in PBS/0.01% sodium azide solution. For in situ hybridization and the mRNA/protein 
colocalization experiments in Figures 5B and S7A, 16 μm thickness were collected. 
 
Immunohistochemistry 
Fixed brain sections were washed with PBS three times at room temperature prior to the procedure to remove 
the sucrose and freezing compound residue. The sections were then incubated with Blocking solution (5% goat 
serum, 0.5% (v/v) Triton X-100, PBS) for one hour at room temperature, then with the primary antibody and 
DAPI diluted in blocking buffer for 16-20 hours at 4 °C, washed in PBS three times for 30 minutes and 
incubated with secondary antibody diluted in the blocking buffer for up to four hours at room temperature. Next, 
sections were incubated with PBS for 30 minutes three times and mounted with a cover glass (Menzel-Gläser) 
and Immu-Mount mounting medium (Shandon, Thermo-Scientific). For the experiment in Figures 5B and S7A, 
instead of mounting after the hybridization protocol, the sections were subjected to the immunohistochemistry 
as described above.        
 
Antibodies for immunohistochemistry 
Primary antibodies used for immunocytochemistry were used at dilutions indicated: anti-Satb2 (1:500, rabbit, 
home-made; (Ambrozkiewicz et al., 2017)), anti-Bcl11b (1:500, rat, Abcam, 25B6, anti-Ctip2), anti-GFP 
(1:1000, goat, Rockland), anti-Cre (1:1000, rabbit, SySy), anti-Tbr2 (1:300, rabbit, Abcam), anti-Pax6 (1:500, 
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Imaging of brain coronal cross sections after IUE was performed at the level of primary somatosensory cortex 
primordium. For imaging of the overview of immunostaining, a Leica SPL confocal microscope with 20X, 40X 
and 63X objectives was used. For quantitative imaging of FISH signal, a Leica Sp8 microscope with 40X 
objective was used. Quantification of mRNA cluster sizes, and mRNA and protein localization, was performed 
using ImageJ software.  
 
QUANTIFICATION AND STATISTICAL ANALYSIS 
Quantification of distribution and size of mRNA clusters  
mRNA puncta were manually quantified using ImageJ software. The maximum intensity of confocal image Z-
stacks was projected on a single 2D plane. After thresholding, the images were binarized using the watershed 
segmentation to separate cluster clouds. The number of particles of 0.1 μm2 or bigger were then quantified 
using Measure Particles tool and normalized to the number of DAPI-labeled nuclei in a given cortical area (MZ, 
VZ, etc.). Area of clusters was quantified as well and expressed as an absolute surface. 
 
Quantification of colocalization 
Mander’s colocalization coefficient was quantified for neurons expressing Satb2 and Bcl11b protein and mRNA. 
Protein colocalization was determined manually, and RNA colocalization was quantified using binarized 
images after multiplication. 
 
Quantification of neuronal cell markers 
The manually quantified number of neurons expressing a given marker was normalized to the entire number of 
IUE-labeled neurons or to DAPI-labeled nuclei count. 
 
Statistical analyses 
Statistics in Figures 1H, 5C, 6E, 7F, and S7B were performed using SPSS v.17 (San Diego, USA) or 
GraphPad Prism software. All numerical values and description of statistical tests used, definition of center, 
dispersion, precision, and definition of significance can be found in the Table S5. Prior to comparison of 
experimental groups, normality and log-normality test were performed. 
 
DATA AVAILABILITY 
Code generated during this study is supplied at: https://github.com/ohlerlab/cortexomics. NIH GEO 
depositions: RNA-seq data: GSE157425; Ribo-seq data: GSE169457; tRNA qPCR array data: GSE169621. 
Mass spectrometry data are deposited in the ProteomeXchange: PXD014841.  
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Figure S1. Optimized ribosome protected mRNA fragment purification from neocortex. 
Nuclease digestion for the generation of ribosome protected mRNA fragments (RPFs) from P0 neocortex, with (A) RNAse-I vs. 
(B) a combination of RNAse-T1 & A. Absorbance at 260 nm (A260). Chains of actively translating ribosomes (polysome) 
should be digested into single ribosomes (monosome). RNAse-I, typically used in yeast, was inefficient in neocortex lysates, 
and thus an RNAse-T1 & A protocol was used for this study. (C) Nuclease digestion and purification of neocortex RPFs in 
biological duplicates at each developmental stage with the optimized protocol from (B). Each biological replicate included 17-
40 brains (34-80 neocortex hemispheres) as detailed in the Methods. (D) RPF read length distribution. (E) Correlation 
between biological replicates measured by RNA-seq, Ribo-seq, and calculated TE. Associated with Figure 1. See also Table 
S1.	
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Figure S2. Neocortex RNA-seq, Ribo-seq, MS, and translation efficiency data characteristics. 
(A) River plots demonstrating the number of unique genes detected across all 5 stages measured by RNA-seq, Ribo-seq, or 
mass spectrometry, compared to the number detected in <5 stages. (B) The distribution of translation efficiency (TE) and 
mRNA abundance (TPM) across all measured genes per stage, and (C) fold changes (FC) vs. the earliest stage E12.5. (D) 
The distribution of TE up and down compared to the earliest stage E12.5, with significant genes highlighted in black (p < 0.05). 
(E) TE distribution for genes with increasing start codon occupancy across developmental stages, compared to those without 
start occupancy changes. (F) The association of mRNAs demonstrating start codon occupancy changes with translation in 
neurites vs. the soma of cultured neurons (Zappulo et al., 2017). Associated with Figures 1-2. See also Tables S1-2.	
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Figure S3. Immuno-electron microscopy labeling of ribosomes. 
(A) Raw images of neocortex coronal sections at E12.5 and E15.5 shown in Figure 1G, immunolabeled with anti-
ribosomal protein uS7 followed by 2.5 nm gold secondary (dark black spots), which were automatically detected and 
quantified in FIJI (magenta spots in Figure 1G-H). Electron microscopy was performed in regions corresponding to the 
stem cell niches of the ventricular zone (VZ) and sub-ventricular zone (SVZ), in addition to regions of differentiating 
neurons in the cortical plate (CP), which includes both lower layers (LL) and upper layers (UL) at later stages. 
Quantification of nanogold secondary signal was performed per unit area of the cytoplasm, with nuclei excluded by tracing 
the nuclear membrane (black lines in Figure 1G). (B) Primary antibody leave-out controls were prepared in parallel.	
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Figure S4. Ribosome dwell time analysis. 
5' normalized ribosome-protected mRNA fragment (RPF) density for (A) all codons and (B) the top 3 slowest/fastest codons. 
Plotting the normalized density of Ribo-seq read 5' ends relative to each codon/read length/sample shows two strongly 
variable regions corresponding to 5'- and 3'-end cut site biases during nuclease digestion. A third variable region in between 
corresponds to RPFs with their A/P-sites positioned over the codon.  We infer the location of the A-site as the 3 bp region 
showing the most inter-codon variability, and use the normalized occupancy here to measure codon dwell times, and variance 
between codons. Independently, this region also identifies the location of intra-codon variability between samples. (C) 
Correlation between ribosome dwell time per codon and the optimality of the codon as defined in (dos Reis et al., 2004), with 
the mean across all stages shown. (D) Per codon ribosome dwell time at each developmental stage, separated by G/C 
content for each codon. Associated with Figure 3. See also Table S3. 
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Figure S5. Neocortex tRNA qPCR array. 
Total tRNA levels at each stage measured by qPCR array in biological duplicate, with Ct values for each tRNA isodecoder 
(left) or averaged across isodecoders (right) compared to the mean of 5S and 18S rRNA levels in each sample (delta Ct). 
Associated with Figure 3.	
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Figure S6. Mass spectrometry data, correlation, and principal component analysis. 
(A) Correlation (high, orange; low, purple) between steady-state protein levels measured by MS, and mRNA translation by 
Ribo-seq, or steady-state mRNA by RNA-seq. Correlations shown for all genes, and those with changing protein, TE, and 
mRNA levels. (B) Principal component analysis (PCA) of developmental fold changes in RNA-seq, TE, and MS from the 
earliest stage E12.5. The first four components are shown, with percent variance annotated. Associated with Figure 4. See 
also Table S4.	
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Figure S7. Satb2-/- control for FISH and IHC. 
(A) Fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) probing for Satb2 and Bcl11b mRNA and 
protein, respectively, in wild-type (Satb2+/+) and Satb2 knockout (Satb2-/-) neocortex coronal sections at E14.5. Ventricular 
zone (VZ), cortical plate (CP). (B) Measurement of Satb2 and Bcl11b mRNA cluster sizes in FISH probed neocortex sections 
at three developmental stages. Intermediate zone (IZ), lower layers (LL), upper layers (UL). Mean ± SEM. Associated with 
Figure 5.	
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Figure S8. Neocortex-specific Satb2 activation.  
Satb2 transcription activation visualized in Satb2Cre/+ mice by in utero co-electroporation of the neocortex and ganglionic 
eminence with a loxP-STOP-loxP-tdTomato (Satb2tdTom) fluorescence reporter at E12.5, along with eGFP reporter for all 
transfected cells, and analysis in coronal sections at E13.5. Ventricular zone (VZ), sub-ventricular zone (SVZ), intermediate 
zone (IZ), cortical plate (CP). Associated with Figure 6.	
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